A total of ten studies [11, 16–22, 24, 26] reported the survivin expression in ovarian cancer vs borderline ovarian tumor, with 436 cases of ovarian cancer patients and 190 ovarian borderline tumor patients. This evidence concerns the gene BIRC5 and ovarian cancer.